Skip To Main Content
Lerryn Martin on Muck Rack

Lerryn Martin

As seen in: JD Supra, Lexology, Mondaq, Westlaw Today
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lerryn

Contact Lerryn, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The EU Commission's New Draft Merger Guidelines - Key Takeaways For Pharma Companies

|
By Kyriakos Fountoukakos, Lerryn Martin, Kristien Geeurickx
| Mondaq
Herbert Smith Freehills Kramer LLP are most popular: within Wealth Management, Employment and HR and Technology topic(s) with Inhouse Counsel On 30 April 2026, the EU Commission published its draft revised EU merger guidelines (Guidelines) which could come into effect by the end of 2026. Whilst in draft form, the Guidelines reflect the direction of travel for the regime, and the Commission has already started to adopt an approach aligned with them.
Open in Who Shared Issue with article?

Self-driving vehicles take to the road: UK government publishes pilot scheme guidance

|
By Angela Liu, Roddy Martin, Lerryn Martin
| Westlaw Today Verified
The UK government's self-driving vehicle pilot scheme permits the operation of autonomous vehicles (AVs) on public roads without a human driver for the first time. This marks a significant milestone on the UK's AV journey, since previous trials have...
Open in Who Shared Issue with article?

Pharmaceuticals: M&A Revival

|
By Alan F Montgomery, Lerryn Martin, Dylan Kennett
| Mondaq
Alan Montgomery’s articles from Herbert Smith Freehills Kramer LLP are most popular: with Senior Company Executives, HR and Finance and Tax Executives with readers working within the Technology and Law Firm industries 2025 was another turbulent year for the pharma industry as heightened uncertainty, particularly in the US, prevailed.
Open in Who Shared Issue with article?
See all 20 articles